company

FELIX FARMASI AS

3019 DRAMMEN

Return on Equity
−147,45 %
Current Ratio
1,13
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue11 904 000
Net Income−289 000
Total Assets1 693 000
Total Equity196 000
Income (NOK)2022
Revenue11 904 000
Expenditure12 273 000
Operating Profit−369 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−369 000
Tax−81 000
Net Income−289 000
Balance (NOK)2022
Total Fixed Assets3 000
Total Current Assets1 690 000
Total Assets1 693 000
Total Retained Equity2 000
Total Equity196 000
Total Long-Term Debt0
Total Current Debt1 497 000
Total Equity and Debt1 693 000
Cash flow (NOK)2022
Sales Income11 891 000
Other Income12 000
Revenue11 904 000
Cost of Goods Sold9 168 000
Salary Costs2 180 000
Depreciation0
Impairment0
Expenditure12 273 000
Operating Profit−369 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−289 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets3 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets3 000
Stock607 000
Total Investments0
Cash, Bank378 000
Total Current Assets1 690 000
Total Assets1 693 000
Total Equity196 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 035 000
Unpaid Taxes218 000
Dividends0
Other Current Debt245 000
Total Current Debt1 497 000
Total Equity and Debt1 693 000
Financial indicators2022
Return on Equity−147,45 %
Debt-to-Equity Ratio0
Operating Profit Margin−3,1 %
Current Ratio1,13
Quick Ratio1,9
Equity Ratio0,12
Gross Profit Margin22,98 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English